Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot-Marie-Tooth disease type 1A (CMT1A) rats.

Saved in:
Bibliographic Details
Title: Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot-Marie-Tooth disease type 1A (CMT1A) rats.
Authors: Prukop T; Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.; Institute of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, Germany., Wernick S; Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.; Department of Clinical Neurophysiology, University Medical Center Göttingen, Göttingen, Germany., Boussicault L; Pharnext, Issy-Les-Moulineaux, France., Ewers D; Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.; Department of Clinical Neurophysiology, University Medical Center Göttingen, Göttingen, Germany., Jäger K; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany., Adam J; Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany., Winter L; Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany., Quintes S; Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.; Department of Clinical Neurophysiology, University Medical Center Göttingen, Göttingen, Germany., Linhoff L; Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.; Department of Clinical Neurophysiology, University Medical Center Göttingen, Göttingen, Germany., Barrantes-Freer A; Department of Neuropathology, University Medical Center Leipzig, Leipzig, Germany., Bartl M; Department of Clinical Neurophysiology, University Medical Center Göttingen, Göttingen, Germany., Czesnik D; Department of Clinical Neurophysiology, University Medical Center Göttingen, Göttingen, Germany., Zschüntzsch J; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany., Schmidt J; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany., Primas G; Pharnext, Issy-Les-Moulineaux, France., Laffaire J; Pharnext, Issy-Les-Moulineaux, France., Rinaudo P; Pharnext, Issy-Les-Moulineaux, France., Brureau A; Pharnext, Issy-Les-Moulineaux, France., Nabirotchkin S; Pharnext, Issy-Les-Moulineaux, France., Schwab MH; Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany., Nave KA; Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany., Hajj R; Pharnext, Issy-Les-Moulineaux, France., Cohen D; Pharnext, Issy-Les-Moulineaux, France., Sereda MW; Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.; Department of Clinical Neurophysiology, University Medical Center Göttingen, Göttingen, Germany.
Source: Journal of neuroscience research [J Neurosci Res] 2020 Oct; Vol. 98 (10), pp. 1933-1952. Date of Electronic Publication: 2020 Jun 26.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Interscience Country of Publication: United States NLM ID: 7600111 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4547 (Electronic) Linking ISSN: 03604012 NLM ISO Abbreviation: J Neurosci Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1097-4547
DOI:10.1002/jnr.24679